Evidence map›Paper›PMID 31194844›Full record

ArticlePLoS pathogens2019

TLR11-independent inflammasome activation is critical for CD4+ T cell-derived IFN-γ production and host resistance to Toxoplasma gondii.

Américo H López-Yglesias, Ellie Camanzo, Andrew T Martin, Alessandra M Araujo, Felix Yarovinsky

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Cysteine-S-nitrosylation inhibits Rop5-mediated immune evasion inbioRxiv : the preprint server for biology · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. The emerging role ofFrontiers in immunology · 2024
    Review
  15. Review
  16. Cells · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. IL-1R Regulates Disease Tolerance and Cachexia inJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Américo H López-YglesiasCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, NY United States of America.
Ellie CamanzoCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, NY United States of America.ORCID 0000-0002-0151-077X
Andrew T MartinCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, NY United States of America.ORCID 0000-0002-5790-3054
Alessandra M AraujoCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, NY United States of America.
Felix YarovinskyCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, NY United States of America.ORCID 0000-0001-5825-8002
University of Rochester · US

Funding

Mucosal immunity to Toxoplasma gondiiR01AI136538 · NIAID · UNIVERSITY OF ROCHESTER · PI Felix Yarovinsky · 2018 to 2026
$4.0M
Neutrophil IFN-gamma in host defense and inflammationR01AI121090 · NIAID · UNIVERSITY OF ROCHESTER · PI YAROVINSKY, FELIX · 2016 to 2020
$2.3M
Myeloid innate immune T-bet functions in host defense to Toxoplasma gondiiF32AI138414 · NIAID · UNIVERSITY OF ROCHESTER · PI LOPEZ-YGLESIAS, AMERICO HARRY · 2018 to 2019
$104k
NIAID NIH HHS F32 AI138414NIAID NIH HHS R01 AI121090NIAID NIH HHS R01 AI136538
6 · The paper itself

Abstract

Innate recognition of invading intracellular pathogens is essential for regulating robust and rapid CD4+ T cell effector function, which is critical for host-mediated immunity. The intracellular apicomplexan parasite, Toxoplasma gondii, is capable of infecting almost any nucleated cell of warm-blooded animals, including humans, and establishing tissue cysts that persist throughout the lifetime of the host. Recognition of T. gondii by TLRs is essential for robust IL-12 and IFN-γ production, two major cytokines involved in host resistance to the parasite. In the murine model of infection, robust IL-12 and IFN-γ production have been largely attributed to T. gondii profilin recognition by the TLR11 and TLR12 heterodimer complex, resulting in Myd88-dependent IL-12 production. However, TLR11 or TLR12 deficiency failed to recapitulate the acute susceptibility to T. gondii infection seen in Myd88-/- mice. T. gondii triggers inflammasome activation in a caspase-1-dependent manner resulting in cytokine release; however, it remains undetermined if parasite-mediated inflammasome activation impacts IFN-γ production and host resistance to the parasite. Using mice which lack different inflammasome components, we observed that the inflammasome played a limited role in host resistance when TLR11 remained functional. Strikingly, in the absence of TLR11, caspase-1 and -11 played a significant role for robust CD4+ TH1-derived IFN-γ responses and host survival. Moreover, we demonstrated that in the absence of TLR11, production of the caspase-1-dependent cytokine IL-18 was sufficient and necessary for CD4+ T cell-derived IFN-γ responses. Mechanistically, we established that T. gondii-mediated activation of the inflammasome and IL-18 were critical to maintain robust CD4+ TH1 IFN-γ responses during parasite infection in the absence of TLR11.

Indexed as

Immunity, InnateAnimalsCaspase 1CaspasesCaspases, InitiatorCD4-Positive T-LymphocytesInflammasomesInterferon-gammaInterleukin-18MiceMice, KnockoutToll-Like ReceptorsToxoplasmaToxoplasmosis, AnimalCasp1 protein, mouseCasp4 protein, mouseCaspase 1CaspasesCaspases, InitiatorIFNG protein, mouseInflammasomesInterferon-gammaInterleukin-18Tlr11 protein, mouseTlr12 protein, mouseToll-Like Receptors

Identifiers

PMID31194844
PMCPMC6599108
OpenAlexW2952659097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.